推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 印度殺蟲(chóng)劑公司(IIL)在第四季度(截止到2015年3月31日)的凈銷(xiāo)售額上升18.9%，達(dá)到16.08億盧比；凈利潤(rùn)提高20%，達(dá)到6180萬(wàn)盧比。該季度農(nóng)藥制劑的銷(xiāo)售額下降2.1%，為10.69億盧比，原藥的銷(xiāo)售額激增202.5%，達(dá)到8.58億盧比。
印度殺蟲(chóng)劑公司2014-15財(cái)年的凈利潤(rùn)增加37.3%，達(dá)到5.49億盧比；凈收入同比增加11.6%，達(dá)到96.42億盧比。原藥和制劑的銷(xiāo)售額分別增加55.5%和4.2%，達(dá)到33.20億盧比和80.40億盧比。
公司強(qiáng)勁的增長(zhǎng)得益于印度市場(chǎng)份額的增加及不斷推出新品以滿足印度農(nóng)戶的不同需求。印度殺蟲(chóng)劑公司(IIL)總經(jīng)理Rajesh Aggarwal稱(chēng)，“去年印度的氣候條件不佳，農(nóng)戶還在夏季遭受較少降雨及在冬季受到大量降雨帶來(lái)的損失。然而，IIL的業(yè)績(jī)搶眼。年報(bào)數(shù)據(jù)清楚地表明公司產(chǎn)品在市場(chǎng)中的持續(xù)增長(zhǎng)。公司致力于擴(kuò)大市場(chǎng)份額及提高農(nóng)戶合理施用農(nóng)藥的意識(shí)，這為公司帶來(lái)了豐厚的回報(bào)。過(guò)去3年左右，公司推出了包括Hakama、Pulsor、Xplode和Logo的系列產(chǎn)品，帶動(dòng)了業(yè)績(jī)的增長(zhǎng)。如果降雨及時(shí)，公司業(yè)績(jī)?nèi)詫?huì)保持增長(zhǎng)態(tài)勢(shì)?！?/p>
